We then examined the acetylation levels of endogenous RAN in CRC cells treated with nicotinamide (NAM), an inhibitor of Sirt family deacetylases, or siRNAs targeting Sirt7. The gene discussed is SIRT7; the disease is colorectal carcinoma.